REVEAL AF: Incidence of AF in High Risk Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 446 participants.

Also called NCT01727297

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 446 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01727297
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Germany, Italy, Netherlands, Slovenia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01727297. Allocation not applicable; no masking; primary purpose screening. Start 2012-11-13 (actual); primary completion 2017-01-13 (actual). Results posted on 2018-03-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REVEAL AF: Incidence of AF in High Risk Patients
Intervention (Device)
REVEAL Implantable Cardiac Monitor
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct01727297
Content hash
ee553a3e3b0f0294ccf683748ad044e244f4422a625520afda53a0d1eff87463